康拓紅外(300455.SZ):控股股東協議轉讓3178.61萬股完成過户登記
格隆匯12月25日丨康拓紅外(300455.SZ)發佈公告,公司於近日收到公司控股股東航天神舟投資管理有限公司(以下簡稱“神舟投資”)的通知,其以協議轉讓的方式向中國空間技術研究院轉讓其持有的公司無限售流通股3178.61萬股股份的事宜,已在中國證券登記結算有限責任公司深圳分公司辦理完成過户登記手續。
根據披露,神舟投資於2019年11月27日與中國空間技術研究院簽署了《北京康拓紅外技術股份有限公司之股份轉讓協議》。神舟投資以協議轉讓的方式向中國空間技術研究院轉讓其持有的公司無限售流通股3178.61萬股股份,佔目前公司總股本的5.00%。本次股份協議轉讓的價格為8.91元/股,股份轉讓總價款共計人民幣約2.8321億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.